

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | porphyrin-containing compound metabolic process (GO:0006778) | 9.88822616 |
| 2 | heme biosynthetic process (GO:0006783) | 9.50376333 |
| 3 | erythrocyte maturation (GO:0043249) | 9.41951617 |
| 4 | erythrocyte development (GO:0048821) | 8.99324465 |
| 5 | heme metabolic process (GO:0042168) | 8.16123819 |
| 6 | response to methylmercury (GO:0051597) | 6.73142729 |
| 7 | regulation of response to osmotic stress (GO:0047484) | 6.58822429 |
| 8 | myeloid cell development (GO:0061515) | 6.47208726 |
| 9 | antibacterial humoral response (GO:0019731) | 6.23793705 |
| 10 | tetrapyrrole metabolic process (GO:0033013) | 6.15409879 |
| 11 | innate immune response in mucosa (GO:0002227) | 6.02706312 |
| 12 | disruption of cells of other organism (GO:0044364) | 5.97984033 |
| 13 | killing of cells of other organism (GO:0031640) | 5.97984033 |
| 14 | antimicrobial humoral response (GO:0019730) | 5.73537697 |
| 15 | defense response to fungus (GO:0050832) | 5.68640763 |
| 16 | hydrogen peroxide catabolic process (GO:0042744) | 5.17803172 |
| 17 | glycine transport (GO:0015816) | 5.10823457 |
| 18 | mucosal immune response (GO:0002385) | 4.87647689 |
| 19 | one-carbon compound transport (GO:0019755) | 4.83001141 |
| 20 | response to insecticide (GO:0017085) | 4.72788681 |
| 21 | response to lead ion (GO:0010288) | 4.67955871 |
| 22 | organ or tissue specific immune response (GO:0002251) | 4.54521248 |
| 23 | response to arsenic-containing substance (GO:0046685) | 4.37332708 |
| 24 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.21874483 |
| 25 | erythrocyte differentiation (GO:0030218) | 4.17704672 |
| 26 | bicarbonate transport (GO:0015701) | 4.14070907 |
| 27 | granulocyte differentiation (GO:0030851) | 4.07947244 |
| 28 | positive regulation of granulocyte differentiation (GO:0030854) | 4.02415404 |
| 29 | actin filament capping (GO:0051693) | 4.02290962 |
| 30 | negative regulation of viral entry into host cell (GO:0046597) | 3.98817827 |
| 31 | response to fungus (GO:0009620) | 3.95324400 |
| 32 | definitive hemopoiesis (GO:0060216) | 3.93957147 |
| 33 | megakaryocyte development (GO:0035855) | 3.93407445 |
| 34 | pigment biosynthetic process (GO:0046148) | 3.74624777 |
| 35 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.69548006 |
| 36 | positive regulation of fibroblast migration (GO:0010763) | 3.69038858 |
| 37 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.68162352 |
| 38 | regulation of platelet aggregation (GO:0090330) | 3.64736146 |
| 39 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60118079 |
| 40 | regulation of erythrocyte differentiation (GO:0045646) | 3.49668172 |
| 41 | cellular response to arsenic-containing substance (GO:0071243) | 3.49585006 |
| 42 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.48173483 |
| 43 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.48173483 |
| 44 | iron ion import (GO:0097286) | 3.42293072 |
| 45 | platelet formation (GO:0030220) | 3.42126970 |
| 46 | pigment metabolic process (GO:0042440) | 3.41244639 |
| 47 | hydrogen peroxide metabolic process (GO:0042743) | 3.39111983 |
| 48 | embryonic hemopoiesis (GO:0035162) | 3.38318053 |
| 49 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.34524722 |
| 50 | regulation of RNA export from nucleus (GO:0046831) | 3.33440536 |
| 51 | positive regulation of erythrocyte differentiation (GO:0045648) | 3.30099339 |
| 52 | protein targeting to plasma membrane (GO:0072661) | 3.26628760 |
| 53 | modulation by virus of host process (GO:0019054) | 3.24163682 |
| 54 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.19115862 |
| 55 | cellular response to virus (GO:0098586) | 3.15545104 |
| 56 | detection of bacterium (GO:0016045) | 3.15134509 |
| 57 | cell killing (GO:0001906) | 3.14513267 |
| 58 | negative regulation of actin filament depolymerization (GO:0030835) | 3.13556643 |
| 59 | protein-cofactor linkage (GO:0018065) | 3.11902581 |
| 60 | regulation of viral entry into host cell (GO:0046596) | 3.10337167 |
| 61 | response to peptidoglycan (GO:0032494) | 3.06757547 |
| 62 | granulocyte activation (GO:0036230) | 3.02737721 |
| 63 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.97514395 |
| 64 | detection of other organism (GO:0098543) | 2.96340716 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 2.95638029 |
| 66 | neutrophil activation (GO:0042119) | 2.87184508 |
| 67 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.82690202 |
| 68 | hepatocyte apoptotic process (GO:0097284) | 2.81584443 |
| 69 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.81545941 |
| 70 | cellular response to dexamethasone stimulus (GO:0071549) | 2.78166513 |
| 71 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.77521623 |
| 72 | N-terminal protein amino acid acetylation (GO:0006474) | 2.76539051 |
| 73 | hemopoiesis (GO:0030097) | 2.76043826 |
| 74 | defense response to Gram-positive bacterium (GO:0050830) | 2.74703270 |
| 75 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.74242929 |
| 76 | regulation of granulocyte differentiation (GO:0030852) | 2.67913791 |
| 77 | modulation by symbiont of host cellular process (GO:0044068) | 2.67521232 |
| 78 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.67012379 |
| 79 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.66477168 |
| 80 | superoxide anion generation (GO:0042554) | 2.62100029 |
| 81 | iron ion homeostasis (GO:0055072) | 2.61128281 |
| 82 | purine-containing compound salvage (GO:0043101) | 2.56367552 |
| 83 | mitochondrion degradation (GO:0000422) | 2.55556637 |
| 84 | response to dexamethasone (GO:0071548) | 2.54712561 |
| 85 | DNA topological change (GO:0006265) | 2.53040033 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 2.48690769 |
| 87 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.46463267 |
| 88 | cofactor biosynthetic process (GO:0051188) | 2.42336588 |
| 89 | negative regulation of actin filament polymerization (GO:0030837) | 2.41480806 |
| 90 | regulation of mast cell degranulation (GO:0043304) | 2.38288187 |
| 91 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.36309127 |
| 92 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.34911306 |
| 93 | regulation of growth of symbiont in host (GO:0044126) | 2.34911306 |
| 94 | protoporphyrinogen IX metabolic process (GO:0046501) | 16.1362771 |
| 95 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 13.2012447 |
| 96 | hemoglobin metabolic process (GO:0020027) | 12.4708602 |
| 97 | porphyrin-containing compound biosynthetic process (GO:0006779) | 11.7006719 |
| 98 | * oxygen transport (GO:0015671) | 11.5744963 |
| 99 | * gas transport (GO:0015669) | 10.6115961 |
| 100 | tetrapyrrole biosynthetic process (GO:0033014) | 10.3842987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 8.22079901 |
| 2 | GATA1_19941826_ChIP-Seq_K562_Human | 6.35682069 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.98711027 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.61890127 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.53920402 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.21657164 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.17276696 |
| 8 | * GATA2_19941826_ChIP-Seq_K562_Human | 3.74032200 |
| 9 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 3.45182550 |
| 10 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 3.43250041 |
| 11 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 3.30593185 |
| 12 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.52124078 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45718498 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31167030 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20648600 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.10904835 |
| 17 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.06134226 |
| 18 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.96992830 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 1.93491664 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.88676137 |
| 21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86671489 |
| 22 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.83515102 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75249813 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75125449 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.69510270 |
| 26 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.67394452 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66867692 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65117510 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59214355 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.55756697 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54780044 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54388114 |
| 33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.53522853 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53324129 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48628601 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47920274 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47314605 |
| 38 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37192288 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36015462 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34732794 |
| 41 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33876276 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31777499 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30377229 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27806485 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26204042 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24552561 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23520373 |
| 48 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.21157624 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20416843 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19334066 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18018364 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16490899 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14032635 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.12887980 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12851801 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09421357 |
| 57 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.09232603 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.05343895 |
| 59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04961857 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04860490 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02491195 |
| 62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01814560 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.01268609 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99446138 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98630385 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98001675 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97681509 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.96805898 |
| 69 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96477937 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95245870 |
| 71 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95221662 |
| 72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94782671 |
| 73 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94263457 |
| 74 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.94196043 |
| 75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93657926 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.92010836 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91677794 |
| 78 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.89920354 |
| 79 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.89854162 |
| 80 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.88497827 |
| 81 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87279264 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85352515 |
| 83 | P68_20966046_ChIP-Seq_HELA_Human | 0.85064643 |
| 84 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.84271116 |
| 85 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82650013 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82054191 |
| 87 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.81837417 |
| 88 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.81786760 |
| 89 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.81402164 |
| 90 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.81270072 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80577424 |
| 92 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.79100707 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.79023758 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.78896947 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.78878147 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78594237 |
| 97 | KDM2B_26808549_Chip-Seq_K562_Human | 0.77770497 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77005795 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77001262 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76050736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 5.16102975 |
| 2 | MP0005397_hematopoietic_system_phenotyp | 3.44763444 |
| 3 | MP0001545_abnormal_hematopoietic_system | 3.44763444 |
| 4 | MP0003303_peritoneal_inflammation | 2.94930175 |
| 5 | MP0009278_abnormal_bone_marrow | 2.25253728 |
| 6 | MP0005464_abnormal_platelet_physiology | 2.08198563 |
| 7 | MP0004147_increased_porphyrin_level | 10.9311940 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 10.1774213 |
| 9 | MP0008260_abnormal_autophagy | 1.95100144 |
| 10 | MP0005636_abnormal_mineral_homeostasis | 1.73768921 |
| 11 | MP0003186_abnormal_redox_activity | 1.70979929 |
| 12 | MP0004808_abnormal_hematopoietic_stem | 1.62936628 |
| 13 | MP0003111_abnormal_nucleus_morphology | 1.59333687 |
| 14 | MP0003878_abnormal_ear_physiology | 1.43535330 |
| 15 | MP0005377_hearing/vestibular/ear_phenot | 1.43535330 |
| 16 | MP0002398_abnormal_bone_marrow | 1.41905047 |
| 17 | MP0003045_fibrosis | 1.40675116 |
| 18 | MP0000685_abnormal_immune_system | 1.40111622 |
| 19 | MP0008995_early_reproductive_senescence | 1.38228068 |
| 20 | MP0003172_abnormal_lysosome_physiology | 1.36787732 |
| 21 | MP0001529_abnormal_vocalization | 1.34514732 |
| 22 | MP0002822_catalepsy | 1.31965316 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.31220473 |
| 24 | MP0002722_abnormal_immune_system | 1.30844815 |
| 25 | MP0000689_abnormal_spleen_morphology | 1.26461868 |
| 26 | MP0005025_abnormal_response_to | 1.16460295 |
| 27 | MP0009765_abnormal_xenobiotic_induced | 1.12813292 |
| 28 | MP0009785_altered_susceptibility_to | 1.12388471 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.11636991 |
| 30 | MP0000749_muscle_degeneration | 1.11291563 |
| 31 | MP0009931_abnormal_skin_appearance | 1.05942843 |
| 32 | MP0002429_abnormal_blood_cell | 1.05848547 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.04702506 |
| 34 | MP0005076_abnormal_cell_differentiation | 1.04411596 |
| 35 | MP0009764_decreased_sensitivity_to | 1.03045799 |
| 36 | MP0003436_decreased_susceptibility_to | 1.00565506 |
| 37 | MP0002132_abnormal_respiratory_system | 1.00523595 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 0.96528302 |
| 39 | MP0005451_abnormal_body_composition | 0.95147318 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 0.94816982 |
| 41 | MP0002095_abnormal_skin_pigmentation | 0.94197502 |
| 42 | MP0002166_altered_tumor_susceptibility | 0.91923344 |
| 43 | MP0010307_abnormal_tumor_latency | 0.91799283 |
| 44 | MP0002419_abnormal_innate_immunity | 0.91514759 |
| 45 | MP0002405_respiratory_system_inflammati | 0.91265661 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 0.87910747 |
| 47 | MP0008775_abnormal_heart_ventricle | 0.85230289 |
| 48 | MP0000015_abnormal_ear_pigmentation | 0.84851789 |
| 49 | MP0003566_abnormal_cell_adhesion | 0.82233277 |
| 50 | MP0000703_abnormal_thymus_morphology | 0.81002553 |
| 51 | MP0009763_increased_sensitivity_to | 0.77139005 |
| 52 | MP0000716_abnormal_immune_system | 0.73060771 |
| 53 | MP0003879_abnormal_hair_cell | 0.72312962 |
| 54 | MP0002420_abnormal_adaptive_immunity | 0.72244707 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 0.72045261 |
| 56 | MP0000313_abnormal_cell_death | 0.70966641 |
| 57 | MP0005000_abnormal_immune_tolerance | 0.70722891 |
| 58 | MP0002653_abnormal_ependyma_morphology | 0.70526819 |
| 59 | MP0001819_abnormal_immune_cell | 0.70308598 |
| 60 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66716079 |
| 61 | MP0000609_abnormal_liver_physiology | 0.65642365 |
| 62 | MP0003763_abnormal_thymus_physiology | 0.65084022 |
| 63 | MP0003077_abnormal_cell_cycle | 0.64542099 |
| 64 | MP0002019_abnormal_tumor_incidence | 0.62890145 |
| 65 | MP0008874_decreased_physiological_sensi | 0.62755689 |
| 66 | MP0008057_abnormal_DNA_replication | 0.60455608 |
| 67 | MP0008872_abnormal_physiological_respon | 0.60112191 |
| 68 | MP0002332_abnormal_exercise_endurance | 0.58087492 |
| 69 | MP0005501_abnormal_skin_physiology | 0.58049358 |
| 70 | MP0000598_abnormal_liver_morphology | 0.57384977 |
| 71 | MP0005621_abnormal_cell_physiology | 0.57211206 |
| 72 | MP0009643_abnormal_urine_homeostasis | 0.56282110 |
| 73 | MP0008058_abnormal_DNA_repair | 0.54960338 |
| 74 | MP0002009_preneoplasia | 0.54663629 |
| 75 | MP0000343_altered_response_to | 0.52665247 |
| 76 | MP0003786_premature_aging | 0.50948565 |
| 77 | MP0004947_skin_inflammation | 0.50555447 |
| 78 | MP0001915_intracranial_hemorrhage | 0.49940965 |
| 79 | MP0001790_abnormal_immune_system | 0.48993855 |
| 80 | MP0005387_immune_system_phenotype | 0.48993855 |
| 81 | MP0005058_abnormal_lysosome_morphology | 0.48980621 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 0.48121159 |
| 83 | MP0003795_abnormal_bone_structure | 0.47662513 |
| 84 | MP0002080_prenatal_lethality | 0.46658392 |
| 85 | MP0001756_abnormal_urination | 0.45768783 |
| 86 | MP0001845_abnormal_inflammatory_respons | 0.45692033 |
| 87 | MP0004130_abnormal_muscle_cell | 0.45144820 |
| 88 | MP0009697_abnormal_copulation | 0.45061297 |
| 89 | MP0002006_tumorigenesis | 0.44193222 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.43794015 |
| 91 | MP0003724_increased_susceptibility_to | 0.43673769 |
| 92 | MP0005384_cellular_phenotype | 0.42387303 |
| 93 | MP0008770_decreased_survivor_rate | 0.42334677 |
| 94 | MP0000747_muscle_weakness | 0.42286546 |
| 95 | MP0001663_abnormal_digestive_system | 0.41805442 |
| 96 | MP0004957_abnormal_blastocyst_morpholog | 0.40846352 |
| 97 | MP0002452_abnormal_antigen_presenting | 0.40463326 |
| 98 | MP0002083_premature_death | 0.40060743 |
| 99 | MP0001730_embryonic_growth_arrest | 0.39173122 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.38929813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic anemia (HP:0001931) | 7.27828585 |
| 2 | Reticulocytosis (HP:0001923) | 7.15479992 |
| 3 | Abnormal hemoglobin (HP:0011902) | 6.83277434 |
| 4 | Cholelithiasis (HP:0001081) | 6.62636086 |
| 5 | Paralysis (HP:0003470) | 6.41661846 |
| 6 | * Microcytic anemia (HP:0001935) | 6.41640617 |
| 7 | Abnormal gallbladder morphology (HP:0012437) | 5.99723354 |
| 8 | Polycythemia (HP:0001901) | 5.86110858 |
| 9 | Acanthocytosis (HP:0001927) | 5.46907045 |
| 10 | Diaphragmatic weakness (HP:0009113) | 4.82613098 |
| 11 | Abnormality of reticulocytes (HP:0004312) | 4.70000815 |
| 12 | Toxemia of pregnancy (HP:0100603) | 4.59388352 |
| 13 | Ileus (HP:0002595) | 4.47595261 |
| 14 | Hyperbilirubinemia (HP:0002904) | 4.31170072 |
| 15 | Abnormality of the gallbladder (HP:0005264) | 4.30743789 |
| 16 | Abnormality of iron homeostasis (HP:0011031) | 3.87665123 |
| 17 | Prolonged bleeding time (HP:0003010) | 3.72184496 |
| 18 | Cholecystitis (HP:0001082) | 3.56131296 |
| 19 | Abnormal gallbladder physiology (HP:0012438) | 3.56131296 |
| 20 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.41773813 |
| 21 | Pallor (HP:0000980) | 2.90795565 |
| 22 | Petechiae (HP:0000967) | 2.85610424 |
| 23 | Autoamputation (HP:0001218) | 2.81372531 |
| 24 | Nausea (HP:0002018) | 2.79996740 |
| 25 | Abnormality of the fingertips (HP:0001211) | 2.72274604 |
| 26 | Insomnia (HP:0100785) | 2.70975431 |
| 27 | Cutaneous photosensitivity (HP:0000992) | 2.69037019 |
| 28 | Hypertensive crisis (HP:0100735) | 2.65013414 |
| 29 | Hepatocellular carcinoma (HP:0001402) | 2.51189376 |
| 30 | Epistaxis (HP:0000421) | 2.49309124 |
| 31 | Osteomalacia (HP:0002749) | 2.47213354 |
| 32 | Increased serum ferritin (HP:0003281) | 2.43803109 |
| 33 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.40829622 |
| 34 | Cerebral palsy (HP:0100021) | 2.40143384 |
| 35 | Osteomyelitis (HP:0002754) | 2.38721983 |
| 36 | Abnormal number of erythroid precursors (HP:0012131) | 2.37785022 |
| 37 | Abnormality of sodium homeostasis (HP:0010931) | 2.36770602 |
| 38 | Abnormal platelet volume (HP:0011876) | 2.35421420 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 2.31185377 |
| 40 | Increased mean platelet volume (HP:0011877) | 2.26283640 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 2.22882186 |
| 42 | Abnormal platelet function (HP:0011869) | 2.10169468 |
| 43 | Impaired platelet aggregation (HP:0003540) | 2.10169468 |
| 44 | Hypoparathyroidism (HP:0000829) | 2.10132259 |
| 45 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.06314753 |
| 46 | Hyponatremia (HP:0002902) | 2.03420837 |
| 47 | Visual hallucinations (HP:0002367) | 2.01200405 |
| 48 | * Abnormality of the heme biosynthetic pathway (HP:0010472) | 14.3650064 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 12.6451769 |
| 50 | Poikilocytosis (HP:0004447) | 11.5308664 |
| 51 | Paresthesia (HP:0003401) | 1.99468774 |
| 52 | Pustule (HP:0200039) | 1.98419897 |
| 53 | Gastrointestinal dysmotility (HP:0002579) | 1.97608976 |
| 54 | Urticaria (HP:0001025) | 1.96956214 |
| 55 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.95871006 |
| 56 | Recurrent abscess formation (HP:0002722) | 1.90172514 |
| 57 | Diplopia (HP:0000651) | 1.79296308 |
| 58 | Abnormality of binocular vision (HP:0011514) | 1.79296308 |
| 59 | Anhidrosis (HP:0000970) | 1.78710038 |
| 60 | Thrombophlebitis (HP:0004418) | 1.77205564 |
| 61 | Neoplasm of the liver (HP:0002896) | 1.75086579 |
| 62 | Obstructive lung disease (HP:0006536) | 1.72677255 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 1.72677255 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 1.67760554 |
| 65 | Gingival bleeding (HP:0000225) | 1.67086255 |
| 66 | Cellulitis (HP:0100658) | 1.66779435 |
| 67 | Slow saccadic eye movements (HP:0000514) | 1.66611095 |
| 68 | Recurrent bacterial skin infections (HP:0005406) | 1.57971707 |
| 69 | Skin rash (HP:0000988) | 1.52837323 |
| 70 | Eczematoid dermatitis (HP:0000976) | 1.52762188 |
| 71 | Osteolytic defects of the hand bones (HP:0009699) | 1.52268480 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.52268480 |
| 73 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.51057047 |
| 74 | Muscle fiber splitting (HP:0003555) | 1.49206782 |
| 75 | Prenatal maternal abnormality (HP:0002686) | 1.49195596 |
| 76 | Menorrhagia (HP:0000132) | 1.49158705 |
| 77 | Renal tubular acidosis (HP:0001947) | 1.48563332 |
| 78 | Orthostatic hypotension (HP:0001278) | 1.48310062 |
| 79 | Hypertriglyceridemia (HP:0002155) | 1.46726881 |
| 80 | Splenomegaly (HP:0001744) | 1.45401512 |
| 81 | Rectal prolapse (HP:0002035) | 1.43079671 |
| 82 | Anorexia (HP:0002039) | 1.40301708 |
| 83 | Purpura (HP:0000979) | 1.39739180 |
| 84 | Abnormality of renal resorption (HP:0011038) | 1.37874813 |
| 85 | Long clavicles (HP:0000890) | 1.37199272 |
| 86 | Bruising susceptibility (HP:0000978) | 1.35179634 |
| 87 | Abnormality of nail color (HP:0100643) | 1.33490357 |
| 88 | Hepatosplenomegaly (HP:0001433) | 1.31939960 |
| 89 | Spontaneous hematomas (HP:0007420) | 1.30287138 |
| 90 | Albinism (HP:0001022) | 1.29286722 |
| 91 | Gingivitis (HP:0000230) | 1.28931451 |
| 92 | Fatigue (HP:0012378) | 1.27275100 |
| 93 | Abnormality of macrophages (HP:0004311) | 1.27240308 |
| 94 | Erythema (HP:0010783) | 1.26173479 |
| 95 | Bone marrow hypocellularity (HP:0005528) | 1.25845967 |
| 96 | Distal lower limb amyotrophy (HP:0008944) | 1.24397050 |
| 97 | Recurrent viral infections (HP:0004429) | 1.23816785 |
| 98 | Nasal polyposis (HP:0100582) | 1.22924547 |
| 99 | Peripheral hypomyelination (HP:0007182) | 1.22765825 |
| 100 | Leukocytosis (HP:0001974) | 1.22251781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 8.03469688 |
| 2 | PRPF4B | 4.79213990 |
| 3 | MAP2K3 | 4.00814339 |
| 4 | TAOK2 | 3.60774004 |
| 5 | TAOK1 | 3.45966119 |
| 6 | MAP3K11 | 3.05891656 |
| 7 | GRK6 | 3.00803437 |
| 8 | MAP3K3 | 2.44067492 |
| 9 | WNK1 | 2.40818904 |
| 10 | BMX | 2.22486153 |
| 11 | PIM1 | 2.16794196 |
| 12 | DYRK3 | 2.11172050 |
| 13 | CAMK1D | 1.83953501 |
| 14 | RIPK4 | 1.83315341 |
| 15 | STK4 | 1.49113725 |
| 16 | CLK1 | 1.46327841 |
| 17 | MARK3 | 1.36922323 |
| 18 | SYK | 1.34150418 |
| 19 | MAP3K10 | 1.31900680 |
| 20 | PTK2B | 1.27546364 |
| 21 | MAP3K5 | 1.22546248 |
| 22 | RPS6KA5 | 1.20079045 |
| 23 | TNK2 | 1.17227106 |
| 24 | CDK12 | 1.14818393 |
| 25 | MAP3K1 | 1.13618826 |
| 26 | FGR | 1.07693859 |
| 27 | ERN1 | 1.05469530 |
| 28 | TESK2 | 1.01264011 |
| 29 | HIPK2 | 1.00719156 |
| 30 | CAMK1G | 0.96591381 |
| 31 | SCYL2 | 0.96492810 |
| 32 | TRPM7 | 0.93817623 |
| 33 | GRK5 | 0.92343627 |
| 34 | IKBKE | 0.92274174 |
| 35 | ZAP70 | 0.88801716 |
| 36 | PLK3 | 0.86946256 |
| 37 | RPS6KC1 | 0.85413904 |
| 38 | RPS6KL1 | 0.85413904 |
| 39 | SGK3 | 0.78698059 |
| 40 | BRSK1 | 0.78629634 |
| 41 | TEC | 0.77695778 |
| 42 | MAP3K6 | 0.75111958 |
| 43 | LYN | 0.74633040 |
| 44 | MAP2K1 | 0.73647838 |
| 45 | CDK4 | 0.72091469 |
| 46 | RPS6KA6 | 0.72004974 |
| 47 | IKBKB | 0.70836233 |
| 48 | SGK2 | 0.70815743 |
| 49 | DYRK1B | 0.68844845 |
| 50 | BTK | 0.67550166 |
| 51 | STK11 | 0.66909067 |
| 52 | FES | 0.66618875 |
| 53 | SIK3 | 0.64625190 |
| 54 | JAK2 | 0.63620103 |
| 55 | MAP4K1 | 0.63194618 |
| 56 | YES1 | 0.62539338 |
| 57 | MAP2K4 | 0.61811666 |
| 58 | IRAK4 | 0.61592814 |
| 59 | DYRK1A | 0.59432746 |
| 60 | KSR1 | 0.54875271 |
| 61 | TBK1 | 0.54138347 |
| 62 | MAP3K8 | 0.53635543 |
| 63 | MAPK11 | 0.53080592 |
| 64 | SGK1 | 0.50685014 |
| 65 | PLK1 | 0.49825712 |
| 66 | CDK6 | 0.48032044 |
| 67 | PRKAA2 | 0.47701190 |
| 68 | NEK2 | 0.45553099 |
| 69 | SMG1 | 0.42921168 |
| 70 | CAMK4 | 0.42818257 |
| 71 | PLK4 | 0.39881047 |
| 72 | RPS6KA2 | 0.38807813 |
| 73 | AKT1 | 0.38779776 |
| 74 | BRSK2 | 0.38755124 |
| 75 | HCK | 0.38078305 |
| 76 | MAP2K2 | 0.38056936 |
| 77 | BRAF | 0.38050725 |
| 78 | ICK | 0.34933690 |
| 79 | PBK | 0.33816530 |
| 80 | AKT2 | 0.33073439 |
| 81 | TRIB3 | 0.32615169 |
| 82 | CHUK | 0.31758932 |
| 83 | MAPKAPK2 | 0.31647342 |
| 84 | SGK223 | 0.31388783 |
| 85 | SGK494 | 0.31388783 |
| 86 | PRKACG | 0.31263595 |
| 87 | MAPK4 | 0.30747581 |
| 88 | SIK2 | 0.29258302 |
| 89 | PLK2 | 0.28968158 |
| 90 | ABL2 | 0.28929941 |
| 91 | MAPK3 | 0.28553503 |
| 92 | DYRK2 | 0.27676717 |
| 93 | MAPK12 | 0.26867045 |
| 94 | KDR | 0.24106944 |
| 95 | PINK1 | 0.24103991 |
| 96 | MTOR | 0.24033332 |
| 97 | BRD4 | 0.23293685 |
| 98 | CHEK1 | 0.22696367 |
| 99 | BLK | 0.22483884 |
| 100 | MARK2 | 0.21487965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 6.62294234 |
| 2 | Malaria_Homo sapiens_hsa05144 | 5.11681921 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.32734776 |
| 4 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.46513521 |
| 5 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.62131281 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.51691946 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.31697432 |
| 8 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.02608350 |
| 9 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.94281580 |
| 10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.92640675 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82524802 |
| 12 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.73848812 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.67346755 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 1.63229788 |
| 15 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.52763790 |
| 16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.52236993 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.49320716 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.46826418 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.40746949 |
| 20 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.25765980 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.23447959 |
| 22 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.23148181 |
| 23 | Bladder cancer_Homo sapiens_hsa05219 | 1.22128887 |
| 24 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19977591 |
| 25 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.15622462 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.07468922 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05789908 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.04942208 |
| 29 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.04628387 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02304326 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02048464 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01383844 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01338422 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.00696327 |
| 35 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.97836887 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96822992 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 0.94726060 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 0.90188258 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89812274 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89712119 |
| 41 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84516774 |
| 42 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83697058 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 0.83584364 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 0.81570423 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80913785 |
| 46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77229311 |
| 47 | Measles_Homo sapiens_hsa05162 | 0.74269812 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71202237 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70570041 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.69205022 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68802259 |
| 52 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68472111 |
| 53 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.68098717 |
| 54 | Prostate cancer_Homo sapiens_hsa05215 | 0.67354427 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.67146165 |
| 56 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66570340 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65815927 |
| 58 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65486584 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.64573606 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 0.63990438 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63482663 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62469486 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61689374 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60164032 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59521714 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59018509 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58019308 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55953688 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55639029 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54521766 |
| 71 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.52985678 |
| 72 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50927009 |
| 73 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.50312596 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47950448 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46644327 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43448021 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43259509 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41340612 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40628312 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40574477 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38734108 |
| 82 | Melanoma_Homo sapiens_hsa05218 | 0.38014964 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37660541 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36906244 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.36851191 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.35241942 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34440871 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34199185 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.32040783 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.31716913 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31442500 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31436656 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31194919 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.31050938 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29943726 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28582360 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27880064 |
| 98 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.27317178 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25943512 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.25559572 |

